The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia

• Published in: Schizophrenia bulletin Vol. 46; no. 6; pp. 1471 - 1481
• Main Authors: Ulivieri, Martina, Wierońska, Joanna Monika, Lionetto, Luana, Martinello, Katiuscia, Cieslik, Paulina, Chocyk, Agnieszka, Curto, Martina, Di Menna, Luisa, Iacovelli, Luisa, Traficante, Anna, Liberatore, Francesca, Mascio, Giada, Antenucci, Nico, Giannino, Giuseppe, Vergassola, Matteo, Pittaluga, Anna, Bruno, Valeria, Battaglia, Giuseppe, Fucile, Sergio, Simmaco, Maurizio, Nicoletti, Ferdinando, Pilc, Andrzej, Fazio, Francesco
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 01.12.2020
• Subjects: Regular; MK-801; kynurenine pathway; mood disorder; human tissue; electrophysiology; metabotropic glutamate receptor; mass; HPLC-mass; behavior; endogenous metabolite
• ISSN: 0586-7614; 1745-1701
• DOI: 10.1093/schbul/sbaa074

Abstract Cinnabarinic acid (CA) is a kynurenine metabolite that activates mGlu4 metabotropic glutamate receptors. Using a highly sensitive ultra-performance liquid chromatography/tandem mass spectrometry (UPLC/MS-MS) method, we found that CA is present in trace amounts in human brain tissue. CA levels were largely reduced in the prefrontal cortex (PFC) of individuals affected by schizophrenia. This reduction did not correlate with age, sex, duration of the disease, and duration and type of antipsychotic medication and might, therefore, represent a trait of schizophrenia. Interestingly, systemic treatment with low doses of CA (<1 mg/kg, i.p.) showed robust efficacy in several behavioral tests useful to study antipsychotic-like activity in mice and rats and attenuated MK-801-evoked glutamate release. CA failed to display antipsychotic-like activity and inhibit excitatory synaptic transmission in mice lacking mGlu4 receptors. These findings suggest that CA is a potent endogenous antipsychotic-like molecule and reduced CA levels in the PFC might contribute to the pathophysiology of schizophrenia.